Pharmafile
Therapeutic areas in focus
New but controversial ALS drug, Relyviro, approved by FDA
Bio-Rad and Qiagen plan to merge in a deal potentially worth over $10bn
FDA approves Furosemide to treat patients with chronic heart failure
New cancer vaccine may be available by 2030
Johnson & Johnson is planning to acquire Abiomed for $17bn